Sosei Buys Idorsia

In a $466 million agreement, Sosei acquires the Japan and Korea subsidiaries of Idorsia

Source – Sosei Heptares Japan’s Sosei Group has successfully transformed into a commercial-stage pharmaceutical company by acquiring the rights to ...